KMT2A and cancer: Thus, as with ATRX mutation in ALT cancer cells and DNMT3B mutation in ICF syndrome type I fibroblasts, MLL rearrangements in MLL-r ALL would also appear to prevent a negative feedback regulation of TERRA.